Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665672 · ClinicalTrials.gov registry record · NA
Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work
A NA study of Sleep Duration and Psychomotor Performance, sponsored by Daniel Patterson, PhD, NRP.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06665672: Recruiting NA study of Sleep Duration and Psychomotor Performance, sponsored by Daniel Patterson, PhD, NRP.
NCT06665672 is a NA study of Sleep Duration and Psychomotor Performance that is actively recruiting participants, run by Daniel Patterson, PhD, NRP. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06665672, a NA study of Sleep Duration and Psychomotor Performance, is actively recruiting participants, sponsored by Daniel Patterson, PhD, NRP.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. Aim 1: To determine the effect of the ApolloNeuro device on sleep duration, sleep architecture, blood pressure, heart rate variability, and subjective ratings of sleep quality during and after simulated night shift work. Aim 2: To determine the effect of the ApolloNeuro device on post-sleep psychomotor performance.
Primary Outcome
Sleep duration is measured in minutes
Conditions Studied
Interventions
- DEVICE Wrist worn vibro-acoustic device
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-11-26 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06665672 shows while recruiting
NCT06665672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Sleep Duration appearing as the primary indexed condition, and to 1 intervention - of which Wrist worn vibro-acoustic device is the first listed.
NCT06665672 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06665672 about?
NCT06665672 is a clinical study titled "Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work". The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. Aim 1: To determine the effect of the ApolloNeuro device on ...
What is the current status of trial NCT06665672?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-11-26. Estimated completion is 2026-03-31.
What conditions does trial NCT06665672 study?
This clinical trial studies the following conditions: Sleep Duration, Psychomotor Performance.
What interventions are being tested in trial NCT06665672?
The interventions under investigation include: Wrist worn vibro-acoustic device (DEVICE).
Who is sponsoring clinical trial NCT06665672?
This trial is sponsored by Daniel Patterson, PhD, NRP, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06665672 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Duration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06665672's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI